Obesity

Low awareness of GLP-1s globally, but high in the most advanced economies
Healthcare Survey

Low awareness of GLP-1s globally, but high in the most advanced economies

Despite media discussions around the drugs, only around a third across 30 countries have heard about the drugs, with a lot of the discourse taking place via social media according to the Ipsos Health Service Report.
GLP–1s: A Healthcare Revolution? - Ipsos
Healthcare Publication

GLP–1s: A Healthcare Revolution?

One of this century’s biggest game-changers will likely be a novel drug class that’s showing unprecedented success, or the promise of it, in treating some of the world’s most prevalent conditions.